World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
41433
World Ranking
7915
National Ranking
4119

Joel M. Gelfand publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joel M. Gelfand sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 476 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joel M. Gelfand D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joel M. Gelfand sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joel M. Gelfand is affiliated with the University of Pennsylvania in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in related subfields including Immunology, Dermatology, Rheumatology, Economics and Econometrics, and Pathology and Forensic Medicine.

The main topics of their work involve Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Health Systems, Economic Evaluations, Quality of Life, Spondyloarthritis Studies and Treatments, Asthma and respiratory diseases, Vitamin D Research Studies, and Allergic Rhinitis and Sensitization.

Gelfand's publication record features articles predominantly in well-known journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology, JAMA Dermatology, Journal of Psoriasis and Psoriatic Arthritis, and Journal of the European Academy of Dermatology and Venereology.

Among recent papers authored or coauthored by Gelfand are:

  • "Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies" (2020, Journal of the American Academy of Dermatology)
  • "Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures" (2020, Journal of the American Academy of Dermatology)
  • "Ultraviolet germicidal irradiation: Possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic" (2020, Journal of the American Academy of Dermatology)
  • "Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19" (2021, JAMA Network Open)
  • "National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments" (2021, Journal of the American Academy of Dermatology)

Frequent collaborators in their research include:

  • Daniel B. Shin
  • Nehal N. Mehta
  • Maha N. Syed
  • Joy Wan
  • April W. Armstrong

Gelfand's work has been published most often in the Journal of Investigative Dermatology with 49 publications, followed by 25 publications in the Journal of the American Academy of Dermatology, 15 in JAMA Dermatology, and 6 each in the Journal of Psoriasis and Psoriatic Arthritis and the Journal of the European Academy of Dermatology and Venereology.

Best Publications

  • Risk of myocardial infarction in patients with psoriasis.

    Joel M. Gelfand;Andrea L. Neimann;Daniel B. Shin;Xingmei Wang

  • Prevalence of cardiovascular risk factors in patients with psoriasis

    Andrea L. Neimann;Daniel B. Shin;Xingmei Wang;David J. Margolis

  • Psoriasis and comorbid diseases: Epidemiology.

    Junko Takeshita;Sungat Grewal;Sinéad M. Langan;Nehal N. Mehta

  • Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

    Alan Menter;Bruce E. Strober;Daniel H. Kaplan;Dario Kivelevitch

  • The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis: A Population-Based Cohort Study

    Shanu Kohli Kurd;Andrea B Troxel;Paul Crits-Christoph;Joel M Gelfand

  • Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

    Joel M. Gelfand;Rachel Weinstein;Steven B. Porter;Andrea L. Neimann

  • Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

    Nehal N. Mehta;Rahat S. Azfar;Daniel B. Shin;Andrea L. Neimann

  • Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis. Section 3. Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapies

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study

    Joel M. Gelfand;Andrea B. Troxel;James D. Lewis;Shanu Kohli Kurd

  • Epidemiology of psoriatic arthritis in the population of the United States.

    Joel M. Gelfand;Dafna D. Gladman;Philip J. Mease;Nana Smith

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003–2004

    Shanu Kohli Kurd;Joel M. Gelfand

  • Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.

    Sinéad M. Langan;Sinéad M. Langan;Nicole M. Seminara;Daniel B. Shin;Andrea B. Troxel

  • National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

    Alexa B. Kimball;Dafna Gladman;Joel M. Gelfand;Kenneth Gordon

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study

    Howa Yeung;Junko Takeshita;Nehal N. Mehta;Stephen E. Kimmel

  • Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

    K Abuabara;R.S Azfar;D.B Shin;A.L Neimann

  • Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study

    Alexis Ogdie;YiDing Yu;Kevin Haynes;Thorvardur Jon Love

  • Determinants of quality of life in patients with psoriasis: A study from the US population

    Joel M. Gelfand;Steven R. Feldman;Robert S. Stern;John Thomas

  • Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Parallel Randomized Trial

    Alexa B. Kimball;Francisco Kerdel;David Adams;Ulrich Mrowietz

Frequent Co-Authors

David J. Margolis
David J. Margolis University of Pennsylvania
Andrea B. Troxel
Andrea B. Troxel New York University
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
David A. Bluemke
David A. Bluemke University of Wisconsin–Madison
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Jonathan I. Silverberg
Jonathan I. Silverberg George Washington University Hospital
Mark Boguniewicz
Mark Boguniewicz National Jewish Health
Hyon K. Choi
Hyon K. Choi Harvard Medical School
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Abass Alavi
Abass Alavi University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several related online degrees and career pathways you might explore. Many healthcare professionals choose to begin their journey with affordable and flexible education options that allow for work-study balance.

Cheap online FNP programs are a popular choice for registered nurses (RNs) who want to become Family Nurse Practitioners, offering both cost savings and accessible learning. Similarly, affordable nursing programs online can be an excellent entry point for those new to nursing or looking to advance their credentials quickly.

Earning a bachelor’s degree can open more doors in the field. For RNs, RN to BSN online programs provide a streamlined pathway to a Bachelor of Science in Nursing, supporting career advancement and higher earning potential. For those seeking leadership, teaching, or research roles, online PhD nursing programs deliver advanced training and specialized expertise.

Exploring these trusted online options can help prepare you for a wide array of healthcare careers in the USA, making your educational investments both impactful and affordable.

Best Scientists Citing Joel M. Gelfand

Trending Scientists

Recently Published Articles